secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2026-08-06T20:09:38+00:00
Accession:  0001636422-26-000091
Event type: m_and_a
Sentiment:  positive
Materiality: 0.85
Item codes: 1.02, 2.01, 1.01, 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst sells VitalWare for $147M, repays credit facility, Q2 revenue down 13%
--------------------------------------------------------------------------------

- Sold VitalWare to Med-Metrix for $147M cash; used proceeds plus cash on hand to fully repay $160M credit facility.
- Credit facility repayment included $122.8M term loan, $37.1M delayed draw, $3.2M prepayment premium, $0.5M accrued interest.
- Q2 2026 revenue $70.5M (down 13% YoY); net loss $40.5M (vs $41.0M loss in Q2 2025).
- Company expects to eliminate ~$19M annual GAAP interest expense from debt repayment.
- Pro forma shows VitalWare contributed $17.6M revenue in H1 2026; Health Catalyst now focuses on intelligence products.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642226000091/0001636422-26-000091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642226000091/hcat-20260731.htm
  HTML page:      https://secwatch.observer/filing/0001636422-26-000091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer